treosulfan has been researched along with Hypogammaglobulinemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jayakumar, I; Melarcode Ramanan, K; Patel, S; Raj, R; Ravichandran, N; Uppuluri, R; Vaidhyanathan, L; Vellaichamy Swaminathan, V | 1 |
1 other study(ies) available for treosulfan and Hypogammaglobulinemia
| Article | Year |
|---|---|
Treosulfan-based reduced toxicity hematopoietic stem cell transplantation in X-linked agammaglobulinemia: A cost-effective alternative to long-term immunoglobulin replacement in developing countries.
Topics: Agammaglobulinemia; Busulfan; Cost-Benefit Analysis; Developing Countries; Drug Therapy, Combination; Genetic Diseases, X-Linked; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; India; Infant; Male; Transplantation Conditioning | 2020 |